After Wu Xianfa was diagnosed with lung cancer last year, he had surgery to remove part of his lower left lung.
When his doctor recommended chemotherapy to wipe out any remaining cancer cells, Wu refused. Colleagues who had also had lung cancer had died after getting chemotherapy straight after surgery.
Following a friend’s recommendation, the 50-year-old from Shanghai started taking an experimental drug. He signed an agreement with Shanghai Spark Pharmaceutical in April last year to join its trial – and says it has been a boon to his health.
“I get no other treatments besides the drug,” Wu says. “I get regular checks at hospitals and send the reports about my cancer index and other medical
•
Dec 12, 2019